RUNX 1
Alternative Names: RUNX-1Latest Information Update: 12 May 2023
At a glance
- Originator NanoCarrier
- Class Analgesics; Anti-inflammatories; RNA
- Mechanism of Action RNA interference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Phase I Osteoarthritis